BackCitius Oncology Overview

Citius Oncology Common Stock

Track Citius Oncology's common stock ($9.3K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$9298.00
↑ 29.95% YoYΔ $2143.00 vs prior year quarter

Peer average

Loading

Citius Oncology Common Stock History

Loading

Citius Oncology vs. peers: Common Stock Comparison

Loading

Citius Oncology Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Citius Oncology (CTOR) FAQ

Citius Oncology (CTOR) currently reports a common stock of $9.3K as of March 2026. That compares with $7.2K in the prior-year period — up 30.0% year over year. Use the charts on this page to explore Citius Oncology's common stock history and peer comparisons.

Citius Oncology's common stock increased from $7.2K to $9.3K — a 30.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Oncology reported $9.3K in common stock as of March 2026. That compares with $7.2K in the prior-year period — up 30.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $9.3K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.